[go: up one dir, main page]

FI962735A0 - Användning av 2-hydroxi-5-fenylazobensoesyraderivat som preventiv mot tjocktarmkancer och kemoterapeutiskt ämne - Google Patents

Användning av 2-hydroxi-5-fenylazobensoesyraderivat som preventiv mot tjocktarmkancer och kemoterapeutiskt ämne

Info

Publication number
FI962735A0
FI962735A0 FI962735A FI962735A FI962735A0 FI 962735 A0 FI962735 A0 FI 962735A0 FI 962735 A FI962735 A FI 962735A FI 962735 A FI962735 A FI 962735A FI 962735 A0 FI962735 A0 FI 962735A0
Authority
FI
Finland
Prior art keywords
colon cancer
hydroxy
fenylatsobensoehapon
prevention
derivatives
Prior art date
Application number
FI962735A
Other languages
English (en)
Finnish (fi)
Other versions
FI962735A (sv
Inventor
Lorin K Johnson
Marvin H Sleisenger
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Publication of FI962735A0 publication Critical patent/FI962735A0/sv
Publication of FI962735A publication Critical patent/FI962735A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI962735A 1994-01-07 1996-07-03 Användning av 2-hydroxi-5-fenylazobensoesyraderivat som preventiv mot tjocktarmkancer och kemoterapeutiskt ämne FI962735A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/178,578 US5498608A (en) 1994-01-07 1994-01-07 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
PCT/US1995/000055 WO1995018622A1 (en) 1994-01-07 1995-01-06 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Publications (2)

Publication Number Publication Date
FI962735A0 true FI962735A0 (sv) 1996-07-03
FI962735A FI962735A (sv) 1996-08-26

Family

ID=22653104

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962735A FI962735A (sv) 1994-01-07 1996-07-03 Användning av 2-hydroxi-5-fenylazobensoesyraderivat som preventiv mot tjocktarmkancer och kemoterapeutiskt ämne

Country Status (18)

Country Link
US (1) US5498608A (sv)
EP (1) EP0738152B1 (sv)
JP (4) JPH09510958A (sv)
CN (1) CN1140994A (sv)
AT (1) ATE308327T1 (sv)
AU (1) AU691869B2 (sv)
CA (1) CA2180571C (sv)
CZ (1) CZ286460B6 (sv)
DE (1) DE69534564T2 (sv)
DK (1) DK0738152T3 (sv)
ES (1) ES2248796T3 (sv)
FI (1) FI962735A (sv)
HU (1) HUT74512A (sv)
NO (1) NO962841L (sv)
NZ (1) NZ279062A (sv)
RO (1) RO116525B1 (sv)
RU (1) RU2161487C2 (sv)
WO (1) WO1995018622A1 (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
EP1105141B1 (de) 1998-08-06 2003-11-05 Wolfgang Stremmel Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7026318B2 (en) * 2000-06-29 2006-04-11 Shionogi & Co., Ltd. Compounds exhibiting X-type sPLA2 inhibiting effect
ES2254470T3 (es) 2000-08-29 2006-06-16 Nobex Corporation Compuestos inmunorreguladores, derivados de los mismos y su uso.
TWI314457B (sv) * 2001-03-19 2009-09-11 Shionogi & Co
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US7825132B2 (en) 2002-08-23 2010-11-02 Novartis Vaccines And Diagnostics, Inc. Inhibition of FGFR3 and treatment of multiple myeloma
NZ539425A (en) 2002-11-13 2007-11-30 Chiron Corp Methods of treating cancer and related methods
ZA200607435B (en) * 2004-02-06 2009-05-27 Pharmatel Red Pty Ltd As The T Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
BRPI0507891A (pt) 2004-02-20 2007-07-24 Chiron Corp modulação dos processos inflamatório e metastático
FR2867981B1 (fr) 2004-03-24 2008-10-31 Genevrier Sa Lab Utilisation des chondroitine mono-et disulfates en therapeutique
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
AU2005249479B2 (en) * 2004-05-28 2011-09-15 Salix Pharmaceuticals, Inc. Prevention, treatment, and amelioration of radiation induced enteritis
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
NZ564144A (en) 2005-05-13 2009-11-27 Novartis Ag Methods for treating drug resistant cancer
CA2816276A1 (en) 2005-08-24 2007-03-01 Salix Pharmaceuticals, Inc. Balsalazide formulations and manufacture and use thereof
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
RU2354384C1 (ru) * 2007-12-28 2009-05-10 Михаил Владимирович Кутушов Применение органических красителей в качестве средства для лечения онкологических заболеваний
US8569466B2 (en) * 2008-09-10 2013-10-29 Nnochiri Ekwuribe Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
EP2298321A1 (en) 2009-08-26 2011-03-23 Nordic Pharma Novel pharmaceutical compositions for treating IBD
WO2011137103A1 (en) 2010-04-26 2011-11-03 Salix Pharmaceuticals, Ltd. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
CN116173220B (zh) * 2022-03-02 2025-01-10 上海赛金生物医药有限公司 Ctla-4抑制剂和非类固醇抗炎药的抗癌联合治疗方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
GB2080796B (en) * 1980-07-21 1983-10-12 Biorex Laboratories Ltd 2-hydroxy-5-phenylazobenzoic acid derivatives
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
US5162202A (en) * 1989-12-12 1992-11-10 Shamsuddin Abulkalam M Rectal mucus test and kit for detecting cancerous and precancerous conditions
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Also Published As

Publication number Publication date
EP0738152A1 (en) 1996-10-23
DK0738152T3 (da) 2006-01-30
EP0738152A4 (en) 2000-12-13
NZ279062A (en) 1999-11-29
EP0738152B1 (en) 2005-11-02
CA2180571C (en) 2001-03-20
JPH09510958A (ja) 1997-11-04
ES2248796T3 (es) 2006-03-16
CA2180571A1 (en) 1995-07-13
US5498608A (en) 1996-03-12
CZ196796A3 (en) 1996-12-11
HU9601846D0 (en) 1996-09-30
WO1995018622A1 (en) 1995-07-13
NO962841D0 (no) 1996-07-05
JP2010235629A (ja) 2010-10-21
AU691869B2 (en) 1998-05-28
NO962841L (no) 1996-08-29
DE69534564T2 (de) 2006-07-27
JP2005320326A (ja) 2005-11-17
RU2161487C2 (ru) 2001-01-10
DE69534564D1 (de) 2005-12-08
CZ286460B6 (en) 2000-04-12
ATE308327T1 (de) 2005-11-15
JP4601466B2 (ja) 2010-12-22
HUT74512A (en) 1997-01-28
AU1557595A (en) 1995-08-01
JP2006096738A (ja) 2006-04-13
FI962735A (sv) 1996-08-26
CN1140994A (zh) 1997-01-22
RO116525B1 (ro) 2001-03-30

Similar Documents

Publication Publication Date Title
FI962735A0 (sv) Användning av 2-hydroxi-5-fenylazobensoesyraderivat som preventiv mot tjocktarmkancer och kemoterapeutiskt ämne
PT1033981E (pt) Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ES2195344T3 (es) Composicion farmaceutica que presenta una actividad antitumoral mejorada y/o efectos secundarios reducidos, que contiene un agente antitumoral y un derivado de acido hidroximico.
NZ324801A (en) Oral pharmaceutical dosage form containing taxol or etoposide derivatives and a bioenhancer compound
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
ATE212351T1 (de) Androsten-derivate
BR9807234B1 (pt) Composição farmacêutica compreendendo um composto tricílico e uma combinação de miristrato de isopropila e sebacato de dietila, com estabilidade e absorbilidade aumentadas e um pontencial de irritação reduzido
TR199800631A2 (xx) Ecza form�lasyonu.
PL337794A1 (en) Pharmaceutic agent for oral administration containing an active substance and cyclodextrin
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
ES2124477T3 (es) Uso de un fosfato de ascorbilo y tocoferilo para la preparacion de un medicamento para el tratamiento de la pancreatitis.
DE60124144D1 (de) Pharmazeutische zusammenstellungen zur verstärkung der artzneimitteleffekte
IS1885B (is) Þíól afleiður með málmpeptíðasa letjandi virkni, aðferð til framleiðslu þeirra, lyfjaefnablöndur sem innihalda slíkt efnasamband, ásamt notkun á efnasamböndunum til framleiðslu á lyfjum
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
GEP20043377B (en) Pharmaceutical Complex
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
AR012341A1 (es) Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina
FR2715849B1 (fr) Forme d&#39;administration solide à délitescence rapide d&#39;un principe actif.
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.